AstraZeneca

News

HER2 heats up as Seagen licenses RemeGen ADC for $2.6bn

Seagen is a specialist in antibody-drug conjugates, but has looked to Chinese biotech RemeGen for a HER2-targeting candidate that could challenge rival drugs from AstraZeneca/Daiichi Sankyo

News

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

AZ gets European approvals for Forxiga in chronic kidney dis...

AstraZeneca's Forxiga has become the first SGLT2 inhibitor to be approved in Europe for use in people with chronic kidney disease, extending its lead over rival drugs in the class.

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

FDA approves AZ's anifrolumab, ending 10-year lupus drug dro...

AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE) after claiming FDA approval for the drug as an add-on therapy for adults with the a

News

AZ's COVID-19 jab sales top $1.2bn, but come at a loss

AstraZeneca said this morning that it has made $1.2 billion in sales from its COVID-19 vaccine Vaxzevria in the first half of this year, but making it available at no profit had weighed on

News

AZ says second COVID jab dose isn't linked to rare clot reac...

A new analysis has suggested that the rare blood clot side effects linked to AstraZeneca's COVID-19 vaccine Vaxzevria don't occur after a second dose.

News

Regeneron, AZ team up on drugs for obesity "superpower" gene

AstraZeneca has formed a partnership with Regeneron to investigate the potential of treating obesity using drugs directed at GPR75, a protective gene identified by scientists at the Regener

HER2 heats up as Seagen licenses RemeGen ADC for $2.6bn

AZ gets European approvals for Forxiga in chronic kidney dis...

FDA approves AZ's anifrolumab, ending 10-year lupus drug dro...

AZ's COVID-19 jab sales top $1.2bn, but come at a loss

AZ says second COVID jab dose isn't linked to rare clot reac...

Regeneron, AZ team up on drugs for obesity "superpower" gene

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

AstraZeneca

Editor's Picks